Tavapadon met the primary endpoint in the pivotal Phase 3, TEMPO-1 fixed-dose monotherapy trial, demonstrating a statistically significant improvement from baseline in the MDS-UPDRS Parts II and III combined score… Read More
National competition, in collaboration with SpinUp, the University of Toronto’s lab-based life sciences accelerator, demonstrates AbbVie’s commitment to a thriving biotech ecosystem in Canada One Canadian biotech will receive a… Read More
First patients dosed in a Phase 1 study evaluating MES1022, a subcutaneous bone-selective EP4-agonist for bone regeneration $15M in funding raised to date to support clinical trial VANCOUVER, BC – Mesentech,… Read More
Vancouver, B.C., Toronto, ON – On September 30, LifeLabs will pause operations to recognize National Day for Truth and Reconciliation and Orange Shirt Day. This day honours the lost children and… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) welcomes the announcement of the federal government’s commitment to safeguarding the health of Canadians through the creation of Health Emergency Readiness Canada (HERC)…. Read More
